417 related articles for article (PubMed ID: 34319155)
21. TMPRSS2 Independency for Haemagglutinin Cleavage In Vivo Differentiates Influenza B Virus from Influenza A Virus.
Sakai K; Ami Y; Nakajima N; Nakajima K; Kitazawa M; Anraku M; Takayama I; Sangsriratanakul N; Komura M; Sato Y; Asanuma H; Takashita E; Komase K; Takehara K; Tashiro M; Hasegawa H; Odagiri T; Takeda M
Sci Rep; 2016 Jul; 6():29430. PubMed ID: 27389476
[TBL] [Abstract][Full Text] [Related]
22. Host Range of Influenza A Virus H1 to H16 in Eurasian Ducks Based on Tissue and Receptor Binding Studies.
Verhagen JH; Eriksson P; Leijten L; Blixt O; Olsen B; Waldenström J; Ellström P; Kuiken T
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361418
[TBL] [Abstract][Full Text] [Related]
23. Influenza Virus Hemagglutinins H2, H5, H6, and H11 Are Not Targets of Pulmonary Surfactant Protein D:
Parsons LM; An Y; Qi L; White MR; van der Woude R; Hartshorn KL; Taubenberger JK; de Vries RP; Cipollo JF
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826991
[TBL] [Abstract][Full Text] [Related]
24. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
[TBL] [Abstract][Full Text] [Related]
25. Tmprss2 knock-out mice are resistant to H10 influenza A virus pathogenesis.
Lambertz RLO; Gerhauser I; Nehlmeier I; Leist SR; Kollmus H; Pöhlmann S; Schughart K
J Gen Virol; 2019 Jul; 100(7):1073-1078. PubMed ID: 31099738
[TBL] [Abstract][Full Text] [Related]
26. Human matriptase/ST 14 proteolytically cleaves H7N9 hemagglutinin and facilitates the activation of influenza A/Shanghai/2/2013 virus in cell culture.
Whittaker GR; Straus MR
Influenza Other Respir Viruses; 2020 Mar; 14(2):189-195. PubMed ID: 31820577
[TBL] [Abstract][Full Text] [Related]
27. SPINT2 inhibits proteases involved in activation of both influenza viruses and metapneumoviruses.
Straus MR; Kinder JT; Segall M; Dutch RE; Whittaker GR
Virology; 2020 Apr; 543():43-53. PubMed ID: 32056846
[TBL] [Abstract][Full Text] [Related]
28. Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication.
Okumura Y; Takahashi E; Yano M; Ohuchi M; Daidoji T; Nakaya T; Böttcher E; Garten W; Klenk HD; Kido H
J Virol; 2010 May; 84(10):5089-96. PubMed ID: 20219906
[TBL] [Abstract][Full Text] [Related]
29. A mutant H3N2 influenza virus uses an alternative activation mechanism in TMPRSS2 knockout mice by loss of an oligosaccharide in the hemagglutinin stalk region.
Sakai K; Sekizuka T; Ami Y; Nakajima N; Kitazawa M; Sato Y; Nakajima K; Anraku M; Kubota T; Komase K; Takehara K; Hasegawa H; Odagiri T; Tashiro M; Kuroda M; Takeda M
J Virol; 2015 May; 89(9):5154-8. PubMed ID: 25673722
[TBL] [Abstract][Full Text] [Related]
30. Exchange of amino acids in the H1-haemagglutinin to H3 residues is required for efficient influenza A virus replication and pathology in Tmprss2 knock-out mice.
Lambertz RLO; Pippel J; Gerhauser I; Kollmus H; Anhlan D; Hrincius ER; Krausze J; Kühn N; Schughart K
J Gen Virol; 2018 Sep; 99(9):1187-1198. PubMed ID: 30084768
[TBL] [Abstract][Full Text] [Related]
31. H2 influenza A virus is not pathogenic in Tmprss2 knock-out mice.
Lambertz RLO; Gerhauser I; Nehlmeier I; Gärtner S; Winkler M; Leist SR; Kollmus H; Pöhlmann S; Schughart K
Virol J; 2020 Apr; 17(1):56. PubMed ID: 32321537
[TBL] [Abstract][Full Text] [Related]
32. Cleavage activation of human-adapted influenza virus subtypes by kallikrein-related peptidases 5 and 12.
Hamilton BS; Whittaker GR
J Biol Chem; 2013 Jun; 288(24):17399-407. PubMed ID: 23612974
[TBL] [Abstract][Full Text] [Related]
33. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium.
Böttcher E; Matrosovich T; Beyerle M; Klenk HD; Garten W; Matrosovich M
J Virol; 2006 Oct; 80(19):9896-8. PubMed ID: 16973594
[TBL] [Abstract][Full Text] [Related]
34. Gene editing of pigs to control influenza A virus infections.
Kwon T; Artiaga BL; McDowell CD; Whitworth KM; Wells KD; Prather RS; Delhon G; Cigan M; White SN; Retallick J; Gaudreault NN; Morozov I; Richt JA
bioRxiv; 2024 Jan; ():. PubMed ID: 38293027
[TBL] [Abstract][Full Text] [Related]
35. Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice.
Hatesuer B; Bertram S; Mehnert N; Bahgat MM; Nelson PS; Pöhlmann S; Schughart K
PLoS Pathog; 2013; 9(12):e1003774. PubMed ID: 24348248
[TBL] [Abstract][Full Text] [Related]
36. Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells.
Rodriguez-Frandsen A; Martin-Sancho L; Gounder AP; Chang MW; Liu WC; De Jesus PD; von Recum-Knepper J; Dutra MS; Huffmaster NJ; Chavarria M; Mena I; Riva L; Nguyen CB; Dobariya S; Herbert KM; Benner C; Albrecht RA; García-Sastre A; Chanda SK
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776276
[TBL] [Abstract][Full Text] [Related]
37. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
38. The hemagglutinin: a determinant of pathogenicity.
Böttcher-Friebertshäuser E; Garten W; Matrosovich M; Klenk HD
Curr Top Microbiol Immunol; 2014; 385():3-34. PubMed ID: 25031010
[TBL] [Abstract][Full Text] [Related]
39. TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells.
Bertram S; Glowacka I; Blazejewska P; Soilleux E; Allen P; Danisch S; Steffen I; Choi SY; Park Y; Schneider H; Schughart K; Pöhlmann S
J Virol; 2010 Oct; 84(19):10016-25. PubMed ID: 20631123
[TBL] [Abstract][Full Text] [Related]
40. Airway proteases: an emerging drug target for influenza and other respiratory virus infections.
Laporte M; Naesens L
Curr Opin Virol; 2017 Jun; 24():16-24. PubMed ID: 28414992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
